Feb 16, 2017

Snap sets IPO terms

Photo illustration by Greg Ruben / Axios

Snapchat parent company Snap Inc. on Thursday morning disclosed more information about its proposed IPO, including pricing terms. Here's what we've learned:

Top line: Snap plans to offer 200 million shares at between $14 and $16 per share.

Value: If Snap prices in the middle of its range, it would have a market cap of approximately $17.4 billion (albeit at $19.5 billion on a fully-diluted basis). That's more than it was valued at by venture capitalists in March 2015, when it raised $200 million at a $16 billion post-money valuation. But it's significantly lower than the mark it received last May. That discount is also well below the $20 to $30 billion figure that Snap bankers had originally been whispering, and suggests that analyst feedback depressed the price target (which could still change before the actual listing).

Payday: Snap co-founder and CEO Evan Spiegel is selling 16 million shares in the offering, which works out to $240 million at the $15 per share price.

Where: Shares will trade on the New York Stock Exchange.

When: By filing today, Snap is setting itself up to begin trading between March 1-3.

Go deeper

Trump weighs quarantine of New York, New Jersey and Connecticut

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios

President Trump said on Saturday he is considering a "short term" quarantine of New York, New Jersey and parts of Connecticut — states that have already taken steps to quarantine residents and promote social distancing.

The big picture: With 112,000 people infected, the U.S. has the most COVID-19 cases in the world, exceeding China and Italy, per data from Johns Hopkins. A second wave of American cities, including Boston, Detroit, New Orleans and Philadelphia, are reporting influxes of cases.

Go deeperArrowUpdated 8 mins ago - Health

Q&A: Minimizing your coronavirus risk

Illustration: Aïda Amer/Axios

As the coronavirus continues to spread throughout the U.S., Axios is answering readers' questions about the pandemic — how it spreads, who's at risk, and what you can do to stay safe.

What's new: This week, we answer five questions on smokers' vulnerability, food safety, visiting older parents, hair cut needs, and rural vs. urban impact.

The other coronavirus test we need

Illustration: Sarah Grillo/Axios

Researchers are racing to develop tests that detect whether someone may have developed immunity to the coronavirus, which could help society return to normal faster.

Why it matters: These tests could help people know if they are able to go back to work, as well as aid researchers in tracking the scale and death rate of the disease — key data for current and future pandemic policies.

Go deeperArrow36 mins ago - Health